In agreement with the results observed in CRC samples, SST promotor methylation levels were also significantly increased when focused specifically on primary colon cancer samples compared to normal colonic mucosae, i.e. 88% versus 47%, respectively [96]. The gene discussed is SST; the disease is colorectal carcinoma.